FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Tryptase Test System into Class 2

[ Price : $8.95]

Federal Register Final order: FDA classifies tryptase test system devices into Class 2.

FDA Approves New Erectile Dysfunction Indication for Stendraa

[ Price : $8.95]

FDA approves Vivus and Auxiliums Stendraa as an erectile dysfunction treatment that may be taken as early as 15 minutes before sex...

Teva Supports 180-Day Exclusivity Dispute Process

[ Price : $8.95]

Teva voices support for an FDA public process to address issues relating to 180-exclusivity.

FDA Releases Web Course on CMC Requirements for INDs

[ Price : $8.95]

FDA posts a new Web-based training course on Chemistry, Manufacturing, and Controls Perspective of the Investigational New Drug Ap...

Baxter Recalls 1 Lot of Mislabeled Potassium Chloride

[ Price : $8.95]

Baxter International recalls one lot of potassium chloride injection 10mEq per 100mL due to a labeling error on the shipping carto...

Transparency Has Gone Downhill at OGD: GPhA

[ Price : $8.95]

The Generic Pharmaceutical Association tells FDA that transparency has suffered since CDERs Office of Generic Drugs began operatin...

Sanofi, MyoKardia Collaborate on Cardiomyopathy Therapies

[ Price : $8.95]

Sanofi and MyoKardia announce their collaboration to discover and develop first-of-a-kind targeted therapeutics for heritable hear...

OMB OKs Info Collection on Device Informed Consent

[ Price : $8.95]

Federal Register Notice: The Office of Management and Budget approves a collection of information on devices and exception from ge...

FDA Submits Collection of Info on NDAs to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits to the Office of Management and Budget a proposed collection of information on an application...

FDA Issues Emergency Use Authorization for Ebola Diagnostic

[ Price : $8.95]

Federal Register Notice: FDA issues an Emergency Use Authorization for an in vitro diagnostic device for detecting Ebola.